Valeant Pharmaceuticals International Inc
(Toronto Stock Exchange : VRX)

( )
VRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
0.49%14.4214.2%$227.85m
SHPGShire PLC Sponsored ADR
-0.22%142.840.4%$213.78m
PRGOPerrigo Co. Plc
-1.49%77.436.4%$150.76m
MNKMallinckrodt Plc
0.22%37.2017.7%$117.37m
UTHRUnited Therapeutics Corporation
-0.43%130.7213.9%$87.52m
JAZZJazz Pharmaceuticals Plc
-0.16%146.502.2%$80.04m
ENDPEndo International Plc
-0.48%8.348.9%$70.27m
HZNPHorizon Pharma plc
-1.45%12.937.6%$64.54m
ALRAlere Inc.
-0.35%49.392.7%$63.82m
PRXLPAREXEL International Corporation
-0.08%87.667.9%$62.65m
ICPTIntercept Pharmaceuticals, Inc.
-0.14%106.9422.1%$62.05m
MYOKMyoKardia, Inc.
0.80%44.153.0%$54.03m
MDCOMedicines Company
1.92%36.0922.3%$43.38m
PTLAPortola Pharmaceuticals, Inc.
0.59%56.288.9%$42.36m
ICLRICON Plc
-1.03%106.784.2%$41.60m

Company Profile

Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a broad range of pharmaceutical products in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. It operates through the following segments: The Bausch + Lomb/International, The Branded Rx, and The U.S. Diversified products. The Bausch + Lomb/International segment is consist of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment is comprised of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The U.S. Diversified Products segment is the sales in the U.S. of pharmaceutical products, over-the-counter products, and medical device products in the areas of neurology and certain other therapeutics classes, including aesthetics and generic products in the U.S. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.